What is ANI Pharmaceuticals's PP&E (net)?

ANI Pharmaceuticals (ANIP) reported PP&E (net) of $67.12M in Q1 2026.

How has ANI Pharmaceuticals's PP&E (net) changed year-over-year?

ANI Pharmaceuticals's PP&E (net) increased by 15.4% year-over-year, from $58.18M to $67.12M.

What is the long-term trend for ANI Pharmaceuticals's PP&E (net)?

Over 5 years (2020 to 2025), ANI Pharmaceuticals's PP&E (net) has grown at a 8.6% compound annual growth rate (CAGR), from $41.27M to $62.48M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

ANI Pharmaceuticals ANIP PP&E (Net)

PP&E (Net) at other companies

Amneal Pharmaceuticals, Inc.AMRX

$444.61M+4.1%

ViatrisVTRS

$2.53B-4.1%

AnaptysBio, Inc.ANAB

$1.28M-26.5%

ALN

Alnylam PharmaceuticalsALNY

$518.26M+3.9%

Aurinia PharmaceuticalsAUPH

$1.99M-22.9%

AmgenAMGN

$8.22B+23.0%

Other financials

Income statement

See full

Revenue$237.5M+20.5%

Gross profit$143.9M+16.0%

Operating income$38.9M+48.5%

Net income$29.5M+88.1%

EPS (diluted)$1.28+85.5%

Balance sheet

See full

Cash & equivalents$311.2M+108%

Total debt$305.3M-3.5%

Total equity$562.3M+34.3%

Total assets$1.4B+10.0%

Cash flow

See full

Operating cash flow$58.4M+66.8%

CapEx$6.1M+146%

Free cash flow$52.3M+60.8%

Valuation

See full

Market cap$1.89B+18.3%

Enterprise value$1.88B+5.8%

P/E20.5×—

P/S2×-0.3×

Profitability

See full

Gross margin60.8%+1.5pp

Operating margin13.4%—

Net margin10%+8.1pp

FCF margin20.7%+10.8pp

Returns & leverage

See full

Return on equity18.8%+15.6pp

Debt / equity0.5×-0.2×

Current ratio3.1×+0.5×

Where this comes from

Reported directly by ANI Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ANI Pharmaceuticals's PP&E (net)?: ANI Pharmaceuticals (ANIP) reported PP&E (net) of $67.12M in Q1 2026.
How has ANI Pharmaceuticals's PP&E (net) changed year-over-year?: ANI Pharmaceuticals's PP&E (net) increased by 15.4% year-over-year, from $58.18M to $67.12M.
What is the long-term trend for ANI Pharmaceuticals's PP&E (net)?: Over 5 years (2020 to 2025), ANI Pharmaceuticals's PP&E (net) has grown at a 8.6% compound annual growth rate (CAGR), from $41.27M to $62.48M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.